Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 250

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

BRCA1 and BRCA2 mutations and treatment strategies for breast cancer

Open access
Godet, Inês, M. Gilkes, Daniele·2017·Integrative Cancer Science and Therapeutics

Abstract

Breast cancer is a global burden with a woman's lifetime risk of developing breast cancer at 1 in 8.Although breast cancer is a disease that affects mostly women, the lifetime risk in men is about 1 in 1000.Most cases of breast cancer are associated with somatic mutations in breast cells that are acquired during a person's lifetime.In this scenario, the mutations are not inherited and they do not cluster in families.In hereditary breast cancer, the specific genetic factors involved will determine the inherited cancer risk.Inherited mutations in the BRCA1 or BRCA2 genes have been well-described, but mutations in ATM, CDH1, CHEK2, PALB2, PTEN, STK11, and TP53 also confer breast cancer risk.Understanding the functional significance of hereditary mutations has opened new paths for breast cancer prevention and is uncovering promising treatment strategies

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.15761/icst.1000228

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 250

Metadata

Authors
Godet, I., & M. Gilkes, D.
Venue
Integrative Cancer Science and Therapeutics
Published
2017
Volume
4
Issue
1
ISSN
2056-4546 (ISSN-L)
OpenAlex
W2604876648
Cited by
250
References
10
FWCI
10.15
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: BRCA1 and BRCA2 mutations and treatment strategies for breast cancer. https://app.cochat.ai/papers/10.15761/icst.1000228
The paper
Godet, I., & M. Gilkes, D. (2017). BRCA1 and BRCA2 mutations and treatment strategies for breast cancer. Integrative Cancer Science and Therapeutics. https://doi.org/10.15761/icst.1000228

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.